LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,055,000 | +55.0% | 45,192 | +0.7% | 0.59% | +5.7% |
| Q1 2020 | $3,262,000 | -28.1% | 44,859 | +3.2% | 0.56% | -4.0% |
| Q4 2019 | $4,535,000 | -8.1% | 43,483 | -12.3% | 0.58% | -22.3% |
| Q3 2019 | $4,935,000 | -56.2% | 49,578 | -49.7% | 0.75% | -52.3% |
| Q2 2019 | $11,261,000 | -31.9% | 98,649 | -25.0% | 1.56% | -27.2% |
| Q1 2019 | $16,538,000 | +29.1% | 131,559 | +39.4% | 2.15% | +5.2% |
| Q4 2018 | $12,808,000 | -36.1% | 94,382 | +29.3% | 2.04% | -36.9% |
| Q3 2018 | $20,043,000 | -21.0% | 73,020 | -40.4% | 3.23% | -18.1% |
| Q2 2018 | $25,371,000 | +31.5% | 122,463 | +4.8% | 3.95% | -6.8% |
| Q1 2018 | $19,292,000 | +25.8% | 116,808 | +4.3% | 4.24% | +0.8% |
| Q4 2017 | $15,332,000 | +77.8% | 111,971 | +76.8% | 4.20% | +53.9% |
| Q3 2017 | $8,625,000 | +13.5% | 63,346 | +1.2% | 2.73% | +7.1% |
| Q2 2017 | $7,602,000 | +14.7% | 62,623 | -0.0% | 2.55% | +0.8% |
| Q1 2017 | $6,630,000 | +58.4% | 62,640 | +52.1% | 2.53% | +37.6% |
| Q4 2016 | $4,185,000 | -0.4% | 41,190 | +0.0% | 1.84% | +1.6% |
| Q3 2016 | $4,203,000 | -16.3% | 41,177 | -2.2% | 1.81% | -22.3% |
| Q2 2016 | $5,024,000 | -17.3% | 42,120 | -25.7% | 2.33% | -24.0% |
| Q1 2016 | $6,073,000 | -1.4% | 56,711 | -0.2% | 3.06% | +18.8% |
| Q4 2015 | $6,160,000 | +24.9% | 56,818 | -1.3% | 2.58% | +5.9% |
| Q3 2015 | $4,931,000 | -0.5% | 57,571 | +17.2% | 2.44% | +4.5% |
| Q2 2015 | $4,956,000 | -29.7% | 49,115 | -46.3% | 2.33% | -35.2% |
| Q1 2015 | $7,047,000 | +61.6% | 91,384 | +11.5% | 3.60% | +45.6% |
| Q4 2014 | $4,361,000 | +21.5% | 81,952 | +7.3% | 2.47% | +0.7% |
| Q3 2014 | $3,588,000 | -22.5% | 76,366 | +2.7% | 2.45% | -21.4% |
| Q2 2014 | $4,632,000 | -1.9% | 74,363 | +6.0% | 3.12% | -6.7% |
| Q1 2014 | $4,720,000 | +48.9% | 70,162 | +16.5% | 3.34% | +24.5% |
| Q4 2013 | $3,169,000 | – | 60,242 | – | 2.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |